The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Microbiome Based Drugs and Diagnostics Market Research Report 2024

Global Human Microbiome Based Drugs and Diagnostics Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1713755

No of Pages : 93

Ask Your Query

Synopsis

 

The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.

Global Human Microbiome Based Drugs and Diagnostics market is projected to reach US$ 1659 million in 2029, increasing from US$ 827.9 million in 2022, with the CAGR of 10.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Microbiome Based Drugs and Diagnostics market research.

Rising cases of chronic diseases such as diabetes, disorders at early stage and the ability of the drugs to diagnose them and increased awareness among people to maintain healthy lifestyle is driving the growth of this market.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Microbiome Based Drugs and Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Second Genome
  •     Enterome Bioscience
  •     Yakult
  •     Dowdupont
  •     Vedanta BioSciences
  •     Metabiomics Corporation
  •     ViThera Pharmaceuticals
  •     MicroBiome Therapeutics
  •     Osel
  •     Merck

Segment by Type

  •     Therapeutics
  •     Diagnostics

Segment by Application

  •     Clinical Research Institutes
  •     Hospital
  •     Surgical Centers
  •     Others

By Region

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Chapter Outline

The Human Microbiome Based Drugs and Diagnostics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Therapeutics
        1.2.3 Diagnostics
    1.3 Market by Application
        1.3.1 Global Human Microbiome Based Drugs and Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Clinical Research Institutes
        1.3.3 Hospital
        1.3.4 Surgical Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Human Microbiome Based Drugs and Diagnostics Market Perspective (2018-2029)
    2.2 Human Microbiome Based Drugs and Diagnostics Growth Trends by Region
        2.2.1 Global Human Microbiome Based Drugs and Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Human Microbiome Based Drugs and Diagnostics Historic Market Size by Region (2018-2023)
        2.2.3 Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Region (2024-2029)
    2.3 Human Microbiome Based Drugs and Diagnostics Market Dynamics
        2.3.1 Human Microbiome Based Drugs and Diagnostics Industry Trends
        2.3.2 Human Microbiome Based Drugs and Diagnostics Market Drivers
        2.3.3 Human Microbiome Based Drugs and Diagnostics Market Challenges
        2.3.4 Human Microbiome Based Drugs and Diagnostics Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Human Microbiome Based Drugs and Diagnostics Players by Revenue
        3.1.1 Global Top Human Microbiome Based Drugs and Diagnostics Players by Revenue (2018-2023)
        3.1.2 Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Players (2018-2023)
    3.2 Global Human Microbiome Based Drugs and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Human Microbiome Based Drugs and Diagnostics Revenue
    3.4 Global Human Microbiome Based Drugs and Diagnostics Market Concentration Ratio
        3.4.1 Global Human Microbiome Based Drugs and Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Based Drugs and Diagnostics Revenue in 2022
    3.5 Human Microbiome Based Drugs and Diagnostics Key Players Head office and Area Served
    3.6 Key Players Human Microbiome Based Drugs and Diagnostics Product Solution and Service
    3.7 Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Human Microbiome Based Drugs and Diagnostics Breakdown Data by Type
    4.1 Global Human Microbiome Based Drugs and Diagnostics Historic Market Size by Type (2018-2023)
    4.2 Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Type (2024-2029)

 5 Human Microbiome Based Drugs and Diagnostics Breakdown Data by Application
    5.1 Global Human Microbiome Based Drugs and Diagnostics Historic Market Size by Application (2018-2023)
    5.2 Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Human Microbiome Based Drugs and Diagnostics Market Size (2018-2029)
    6.2 North America Human Microbiome Based Drugs and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023)
    6.4 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size (2018-2029)
    7.2 Europe Human Microbiome Based Drugs and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023)
    7.4 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size (2018-2029)
    8.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size (2018-2029)
    9.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023)
    9.4 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size (2018-2029)
    10.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Second Genome
        11.1.1 Second Genome Company Detail
        11.1.2 Second Genome Business Overview
        11.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Introduction
        11.1.4 Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.1.5 Second Genome Recent Development
    11.2 Enterome Bioscience
        11.2.1 Enterome Bioscience Company Detail
        11.2.2 Enterome Bioscience Business Overview
        11.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Introduction
        11.2.4 Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.2.5 Enterome Bioscience Recent Development
    11.3 Yakult
        11.3.1 Yakult Company Detail
        11.3.2 Yakult Business Overview
        11.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Introduction
        11.3.4 Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.3.5 Yakult Recent Development
    11.4 Dowdupont
        11.4.1 Dowdupont Company Detail
        11.4.2 Dowdupont Business Overview
        11.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Introduction
        11.4.4 Dowdupont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.4.5 Dowdupont Recent Development
    11.5 Vedanta BioSciences
        11.5.1 Vedanta BioSciences Company Detail
        11.5.2 Vedanta BioSciences Business Overview
        11.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Introduction
        11.5.4 Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.5.5 Vedanta BioSciences Recent Development
    11.6 Metabiomics Corporation
        11.6.1 Metabiomics Corporation Company Detail
        11.6.2 Metabiomics Corporation Business Overview
        11.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Introduction
        11.6.4 Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.6.5 Metabiomics Corporation Recent Development
    11.7 ViThera Pharmaceuticals
        11.7.1 ViThera Pharmaceuticals Company Detail
        11.7.2 ViThera Pharmaceuticals Business Overview
        11.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Introduction
        11.7.4 ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.7.5 ViThera Pharmaceuticals Recent Development
    11.8 MicroBiome Therapeutics
        11.8.1 MicroBiome Therapeutics Company Detail
        11.8.2 MicroBiome Therapeutics Business Overview
        11.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Introduction
        11.8.4 MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.8.5 MicroBiome Therapeutics Recent Development
    11.9 Osel
        11.9.1 Osel Company Detail
        11.9.2 Osel Business Overview
        11.9.3 Osel Human Microbiome Based Drugs and Diagnostics Introduction
        11.9.4 Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.9.5 Osel Recent Development
    11.10 Merck
        11.10.1 Merck Company Detail
        11.10.2 Merck Business Overview
        11.10.3 Merck Human Microbiome Based Drugs and Diagnostics Introduction
        11.10.4 Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
        11.10.5 Merck Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Therapeutics
    Table 3. Key Players of Diagnostics
    Table 4. Global Human Microbiome Based Drugs and Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Human Microbiome Based Drugs and Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Human Microbiome Based Drugs and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Human Microbiome Based Drugs and Diagnostics Market Share by Region (2018-2023)
    Table 8. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Human Microbiome Based Drugs and Diagnostics Market Share by Region (2024-2029)
    Table 10. Human Microbiome Based Drugs and Diagnostics Market Trends
    Table 11. Human Microbiome Based Drugs and Diagnostics Market Drivers
    Table 12. Human Microbiome Based Drugs and Diagnostics Market Challenges
    Table 13. Human Microbiome Based Drugs and Diagnostics Market Restraints
    Table 14. Global Human Microbiome Based Drugs and Diagnostics Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Human Microbiome Based Drugs and Diagnostics Market Share by Players (2018-2023)
    Table 16. Global Top Human Microbiome Based Drugs and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2022)
    Table 17. Ranking of Global Top Human Microbiome Based Drugs and Diagnostics Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Human Microbiome Based Drugs and Diagnostics Product Solution and Service
    Table 21. Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Human Microbiome Based Drugs and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2018-2023)
    Table 25. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2024-2029)
    Table 27. Global Human Microbiome Based Drugs and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Application (2018-2023)
    Table 29. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Application (2024-2029)
    Table 31. North America Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Second Genome Company Detail
    Table 47. Second Genome Business Overview
    Table 48. Second Genome Human Microbiome Based Drugs and Diagnostics Product
    Table 49. Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 50. Second Genome Recent Development
    Table 51. Enterome Bioscience Company Detail
    Table 52. Enterome Bioscience Business Overview
    Table 53. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product
    Table 54. Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 55. Enterome Bioscience Recent Development
    Table 56. Yakult Company Detail
    Table 57. Yakult Business Overview
    Table 58. Yakult Human Microbiome Based Drugs and Diagnostics Product
    Table 59. Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 60. Yakult Recent Development
    Table 61. Dowdupont Company Detail
    Table 62. Dowdupont Business Overview
    Table 63. Dowdupont Human Microbiome Based Drugs and Diagnostics Product
    Table 64. Dowdupont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 65. Dowdupont Recent Development
    Table 66. Vedanta BioSciences Company Detail
    Table 67. Vedanta BioSciences Business Overview
    Table 68. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product
    Table 69. Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 70. Vedanta BioSciences Recent Development
    Table 71. Metabiomics Corporation Company Detail
    Table 72. Metabiomics Corporation Business Overview
    Table 73. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product
    Table 74. Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 75. Metabiomics Corporation Recent Development
    Table 76. ViThera Pharmaceuticals Company Detail
    Table 77. ViThera Pharmaceuticals Business Overview
    Table 78. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product
    Table 79. ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 80. ViThera Pharmaceuticals Recent Development
    Table 81. MicroBiome Therapeutics Company Detail
    Table 82. MicroBiome Therapeutics Business Overview
    Table 83. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product
    Table 84. MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 85. MicroBiome Therapeutics Recent Development
    Table 86. Osel Company Detail
    Table 87. Osel Business Overview
    Table 88. Osel Human Microbiome Based Drugs and Diagnostics Product
    Table 89. Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 90. Osel Recent Development
    Table 91. Merck Company Detail
    Table 92. Merck Business Overview
    Table 93. Merck Human Microbiome Based Drugs and Diagnostics Product
    Table 94. Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2018-2023) & (US$ Million)
    Table 95. Merck Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Microbiome Based Drugs and Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Human Microbiome Based Drugs and Diagnostics Market Share by Type: 2022 VS 2029
    Figure 3. Therapeutics Features
    Figure 4. Diagnostics Features
    Figure 5. Global Human Microbiome Based Drugs and Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application: 2022 VS 2029
    Figure 7. Clinical Research Institutes Case Studies
    Figure 8. Hospital Case Studies
    Figure 9. Surgical Centers Case Studies
    Figure 10. Others Case Studies
    Figure 11. Human Microbiome Based Drugs and Diagnostics Report Years Considered
    Figure 12. Global Human Microbiome Based Drugs and Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Human Microbiome Based Drugs and Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Human Microbiome Based Drugs and Diagnostics Market Share by Region: 2022 VS 2029
    Figure 15. Global Human Microbiome Based Drugs and Diagnostics Market Share by Players in 2022
    Figure 16. Global Top Human Microbiome Based Drugs and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue in 2022
    Figure 18. North America Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Human Microbiome Based Drugs and Diagnostics Market Share by Country (2018-2029)
    Figure 20. United States Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Human Microbiome Based Drugs and Diagnostics Market Share by Country (2018-2029)
    Figure 24. Germany Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Share by Region (2018-2029)
    Figure 32. China Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Human Microbiome Based Drugs and Diagnostics Market Share by Country (2018-2029)
    Figure 40. Mexico Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Share by Country (2018-2029)
    Figure 44. Turkey Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Second Genome Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 47. Enterome Bioscience Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 48. Yakult Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 49. Dowdupont Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 50. Vedanta BioSciences Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 51. Metabiomics Corporation Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 52. ViThera Pharmaceuticals Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 53. MicroBiome Therapeutics Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 54. Osel Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 55. Merck Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock